![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Glanbia Plc | LSE:GLB | London | Ordinary Share | IE0000669501 | ORD EUR0.06 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.23 | -1.25% | 18.20 | 17.30 | 19.10 | 71 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.43B | 344.5M | 1.2652 | 15.08 | 5.2B |
COMPLETION OF BUYBACK
Glanbia PLC
27 June 2024
Glanbia plc completes EUR50m Share Buyback Programme
Glanbia plc ("Glanbia" or "the Company"), the Global Nutrition Group, is pleased to announce that it has completed its share buyback programme announced on 28 February 2024.
Between 28 February 2024 and 26 June 2024, Glanbia deployed €50 million, repurchasing 2,785,366 ordinary shares on Euronext Dublin at an average price of €17.9510.
Following cancellation of repurchased shares, Glanbia will have 262,286,167 ordinary shares in issue.
J&E Davy completed the buyback programme on behalf of Glanbia independently of, and uninfluenced by, the Company.
****
For further information contact:
Glanbia plc +353 56 777 2200
Mark Garvey, Group Finance Director
Liam Hennigan, Group Secretary and Head of Investor
Relations: +353 86 046 8375
Martha Kavanagh, Director of Corporate Affairs: +353 87 646 2006
1 Year Glanbia Chart |
1 Month Glanbia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions